Asset Manager

Updated:

Organigram Global

Beena Goldenberg runs Organigram Global, the largest Canadian cannabis company by market share after its 2024 Motif Labs deal.

Organigram Global

Organigram Global operates as a fully integrated cannabis consumer-packaged-goods company, anchored by indoor cultivation, extraction, and edibles manufacturing across six Canadian sites. CEO Beena Goldenberg and the senior team run the business from a Toronto corporate hub, while the flagship Moncton, New Brunswick facility houses a three-tier indoor grow capable of producing flower and ready-to-consume formats. The firm's portfolio spans value and premium segments, including the SHRED, BOXHOT, Big Bag o' Buds, DEBUNK, and Edison brands. The strategy centers on occupying multiple price tiers and form factors in Canada's adult-use market while layering on international licensing and supply agreements. Asset-class exposure is concentrated in regulated cannabis cultivation, extraction, and branded consumer products. The Motif Labs acquisition, which closed in 2024, added hydrocarbon and CO₂ extraction capability in Aylmer, Ontario alongside two additional facilities, making Organigram the country's largest operator by market share. Internationally, the firm signed strategic agreements with Germany's Sanity Group, the UK's 4C Labs, and America's Phylos Bioscience in 2023 — a licensing and supply model that extends Organigram's genetic IP and branded products into European medical and adult-use channels without building heavy cultivation assets abroad. Organigram runs five production facilities — Moncton (flower and pre-rolls), Lac-Supérieur (craft flower and hash), Winnipeg (edibles and lozenges), Aylmer (extracts), and a London, Ontario distribution center — alongside the Toronto corporate office. The firm operates as a publicly traded entity listed on the TSX, not as a family office or private investment vehicle. In the 2024 calendar year, Organigram completed the Motif Labs acquisition, which directly expanded its brand portfolio by securing dominant market-share positions in vapes and infused pre-rolls, the two fastest-growing product categories in Canadian cannabis. Organigram's structural differentiator lies in its hybrid of internal CPG brand incubation and acquisition-led category consolidation. Unlike many large Canadian LPs that built greenhouse scale and then struggled to differentiate, Organigram assembled a portfolio of narrowly targeted consumer brands — SHRED for millennial value, BOXHOT for heavy consumers, Monjour for CBD wellness — and paired them with purpose-built extraction and pre-roll automation. This brand-and-automation model lets the firm capture margin across high-volume formats without competing solely on input costs.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

Canada

City

Toronto

Corporate office

Toronto, ON, Canada

Additional offices

Moncton, NB · Lac-Supérieur, QC · Winnipeg, MB · Aylmer, ON · London, ON

Principals

James Yamanaka

Chief Executive Officer

Beena Goldenberg

Chief Executive Officer

Greg Guyatt

Chief Financial Officer

Tim Emberg

President of Organigram Canada

Paolo de Luca

Chief Strategy Officer

Helen Martin

Chief Legal Officer

Valerie Rother

Chief People Officer

Megan McCrae

Senior VP of Corporate Strategy & International Growth

Borna Zlamalik

Senior VP of Innovation and International R&D

Bradley Gunter

Senior VP of Sales

Steven Nazarian

Senior VP of Innovation and Product Development Engineering

Geoffrey Machum

Director

Sector focus

CannabisConsumer Goods

Frequently asked questions

Who runs investment decisions at Organigram Global?

Strategic and investment decisions sit with the executive leadership team led by CEO Beena Goldenberg, with the board of directors providing governance. James Yamanaka is also listed as CEO on the firm's website, suggesting a leadership transition or dual CEO structure. The firm does not disclose an independent investment committee separate from its board.

How is Organigram structured as a corporate entity?

Organigram Global Inc. is a publicly traded company listed on the Toronto Stock Exchange, not a family office or private holding vehicle. It operates as a vertically integrated cannabis consumer packaged goods company, cultivating, extracting, manufacturing, and distributing branded products across Canada and through international supply agreements.

Which sectors does Organigram Global explicitly focus on?

The firm concentrates entirely on regulated cannabis, covering flower, pre-rolls, edibles, vapes, extracts, and lozenges. Its portfolio includes value brands like SHRED, premium lines like Edison, and wellness-oriented products like Monjour. It does not operate outside cannabis or adjacent into broader consumer goods.

Does Organigram Global participate in fund commitments or only direct operating investments?

Organigram invests directly in wholly owned operating subsidiaries and brands, not as a limited partner in external funds. Its corporate development strategy relies on acquisitions like the 2024 Motif Labs deal and structured international partnerships, rather than passive fund commitments or venture-style minority positions.

What is Organigram's known posture on co-investments alongside external companies?

Organigram enters structured strategic agreements rather than blind-pool co-investment arrangements. Its 2023 agreements with Sanity Group, 4C Labs, and Phylos Bioscience are supply, licensing, and intellectual property partnerships, not co-investment vehicles. Each deal includes defined commercial terms for product distribution in specific non-Canadian jurisdictions.

Where does Organigram's revenue come from geographically?

The firm's primary revenue engine is the Canadian adult-use market, served by its cultivation, extraction, and manufacturing facilities in New Brunswick, Quebec, Manitoba, and Ontario. International revenue channels are developing through its German and UK agreements, but the company has not disclosed the percentage of total revenue from non-Canadian sources.

Does Organigram maintain philanthropic structures or community programs?

Organigram participates in the Pledge 1% global movement, committing to donate time, product, or profit to community organizations. Its website emphasizes community investment in the locations where it operates six facilities across five provinces, though the firm does not disclose a separate philanthropic foundation.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo